Patent: 6,670,386
✉ Email this page to a colleague
Summary for Patent: 6,670,386
Title: | Bicyclic modulators of androgen receptor function |
Abstract: | The invention provides compounds of the formula I ##STR1## wherein the substitutents are as described herein. Further provided are methods of using such compounds for the treatment of nuclear hormone receptor-associated conditions, such as age related diseases, for example sarcopenia, and also provided are pharmaceutical compositions containing such compounds. |
Inventor(s): | Sun; Chongqing (East Windsor, NJ), Robl; Jeffrey A. (Newtown, PA), Salvati; Mark E. (Lawrenceville, NJ), Wang; Tammy (Lawrenceville, NJ), Hamann; Lawrence (Cherry Hill, NJ), Augeri; David (Princeton, NJ) |
Assignee: | Bristol-Myers Squibb Company (Princeton, NJ) |
Application Number: | 10/209,461 |
Patent Claims: | see list of patent claims |
Details for Patent 6,670,386
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2021-07-31 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |